Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
06/1998
06/10/1998CN1184104A 3 -hydroxy -pyridine -2 -carboxylic amide ester, and its preparation and its application as medicine
06/09/1998US5763614 1,4-dihydropyridine derivatives and methods of producing the same
06/09/1998US5763487 Skin disorders, cardiovascular disorders and cosmetics
06/09/1998US5763484 Metabolites of linoleic acid and a-linolenic acid
06/09/1998US5763447 Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds
06/09/1998US5763246 DNA encoding arginyl tRNA synthetase from staphylococcus aureus
06/09/1998US5762905 Human neutralizing monoclonal antibodies to respiratory syncytial virus
06/04/1998WO1998023611A1 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023609A1 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023597A1 4,5-diaminopyrimidine derivatives and a method for the preparation thereof
06/04/1998WO1998023596A1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023591A1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
06/04/1998WO1998023294A1 Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation
06/04/1998WO1998023273A1 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators
06/04/1998CA2272900A1 Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation
06/04/1998CA2272683A1 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998CA2272644A1 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists
06/04/1998CA2266605A1 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators
06/04/1998CA2223366A1 3-hydroxypyridine-2-carboxamidoesters, their preparation and their use as pharmaceuticals
06/03/1998EP0845535A2 Leader peptidase (lep) from Streptococcus
06/03/1998EP0844869A1 Method and composition for treating asthma
06/03/1998CN1183786A Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition
06/03/1998CN1183726A Synthetic cryptophycins
06/03/1998CN1183299A Process for preparing particles for acute bronchitis
06/03/1998CN1038585C Process for preparation of 2, 4 - and 2, 5 -substd. pyridine -N -oxides
06/02/1998US5760248 Having improved metabolic stability
06/02/1998US5760084 Treating dermatological disorders
06/02/1998US5760073 Treatment of central nervous system disorders
06/02/1998US5760035 Piperidine compounds substituted with an aminoalkyl group and an aryloxyalkyl group, antiallergens, antiinflammatory agents, immunosuppressants
06/02/1998US5760027 Use of 7-alkylidene cephalosporins to inhibit elastase activity
06/02/1998US5760018 Treatment of pain, inflammation, migraine, emesis
06/02/1998CA2158632C Catechol diether compounds as inhibitors of tnf release
05/1998
05/28/1998WO1998022465A1 A1 adenosine receptor antagonists
05/28/1998WO1998022464A1 Xanthines and their therapeutic use
05/28/1998WO1998022460A1 Bicyclic aryl carboxamides and their therapeutic use
05/28/1998WO1998022457A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998WO1998022453A1 Substituted dihydrobenzofurans as pde inhibitors
05/28/1998WO1998022418A1 Substituted phenols and thiophenols useful as antioxidant agents
05/28/1998WO1998022133A1 NOVEL FabD
05/28/1998WO1998022102A1 Pharmaceutical compositions containing 3-iodo-1,2-propanediol having mucolytic activity
05/28/1998WO1998022099A2 New use of creatine
05/28/1998WO1998021957A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
05/28/1998WO1998016184A3 Purine l-nucleosides, analogs and uses thereof
05/28/1998CA2271963A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
05/28/1998CA2271767A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998CA2268041A1 Xanthines and their therapeutic use
05/28/1998CA2268037A1 Bicyclic aryl carboxamides and their therapeutic use
05/27/1998EP0843676A1 Ipratropium bromide enantiomer with a prolonged duration of action
05/27/1998EP0843549A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4? hydrolase inhibitor
05/27/1998CN1182746A Novel heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
05/27/1998CN1038474C Stable extended release oral dosage composition
05/26/1998US5756733 Vitamin D amide derivatives
05/26/1998US5756503 Analgesics, anesthetics, antiinflammatory agents
05/26/1998US5756499 Substituted imidazole compounds
05/26/1998US5756329 DNA encoding phenylalanyl tRNA synthetase from Staphylococcus aureus
05/26/1998US5756095 Immunoassays for detection of adhesion molecules
05/25/1998CA2215929A1 Novel lep
05/22/1998WO1998021337A2 C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE)
05/22/1998WO1998021332A2 Secreted proteins and polynucleotides encoding them
05/22/1998WO1998021209A1 New imidazopyridines and oxazolopyridines
05/22/1998WO1998021208A1 Benzonaphthyridines as bronchial therapeutics
05/22/1998WO1998021207A1 (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors
05/22/1998WO1998021183A1 Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters, process for preparing the same and their use in medicaments
05/22/1998WO1998021177A1 Benzenesulfonamide derivatives and drugs containing the same
05/22/1998WO1998020873A1 Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom
05/22/1998WO1998020862A1 Immediate wettability water soluble film or water soluble layer for oral application
05/22/1998WO1998020836A2 Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
05/22/1998CA2271724A1 Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom
05/22/1998CA2271673A1 Benzenesulfonamide derivatives and drugs containing the same
05/22/1998CA2270873A1 Secreted proteins and polynucleotides encoding them
05/22/1998CA2269636A1 C3 binding protein of streptococcus pneumoniae
05/22/1998CA2242335A1 Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
05/20/1998EP0843016A2 Staphylococcus FabD (malonylCoA:ACP transacylase) protein
05/20/1998EP0843014A2 Tryptophanyl tRNA synthetase
05/20/1998EP0843011A2 RsbU-1 derived from Staphylococcus
05/20/1998EP0842945A2 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4
05/20/1998EP0842944A2 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4
05/20/1998EP0842943A2 5-Ring heterocycles as inhibitors of leukocyte adhesion and as VLA-4 antagonists
05/20/1998EP0842196A1 Cell adhesion inhibitors
05/20/1998EP0842195A1 Peptide inhibitors of fibronectine
05/20/1998EP0842175A1 Imidazopyridine derivatives
05/20/1998EP0841947A1 Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
05/20/1998EP0841946A1 Methods for treatment of allergic asthma
05/20/1998EP0841937A1 Use of betaglycan to reduce scarring
05/20/1998EP0841929A1 Quinolones and their therapeutic use
05/20/1998EP0841927A1 Quinolones and their therapeutic use
05/20/1998EP0841900A1 Method of detecting lung disease
05/20/1998EP0463053B1 Production and use of anthelmintic agents and protective immunogens
05/20/1998CN1181961A Throat disease curing drop and its preparation
05/20/1998CN1181953A Cough relieving oral medicine
05/19/1998US5753682 Imidazole lipoxygenase inhibitors
05/19/1998US5753666 Quinolones and their therapeutic use
05/19/1998US5753647 Acylamino-substituted hetrazepines
05/19/1998US5753617 Peptide inhibitors of cellular adhesion
05/15/1998CA2220822A1 Heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/15/1998CA2220784A1 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/14/1998WO1998020010A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
05/14/1998WO1998020007A1 Quinolines and their therapeutic use
05/14/1998WO1998019996A1 Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications
05/14/1998WO1998019704A1 Human monoclonal antibodies
1 ... 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 ... 878